Ding J, Tang Z, Liu Y, Chen Q, Tong K, Yang M
Brain Topogr. 2024; 37(6):1195-1202.
PMID: 38896171
DOI: 10.1007/s10548-024-01063-1.
Broomfield N, Blake J, Gracey F, Steverson T
Int J Stroke. 2024; 19(8):857-866.
PMID: 38503711
PMC: 11408949.
DOI: 10.1177/17474930241242952.
Blake J, Gracey F, Whitmore S, Broomfield N
Neuropsychol Rev. 2023; 34(3):768-790.
PMID: 37667057
PMC: 11473539.
DOI: 10.1007/s11065-023-09611-5.
Lee K, Chen J, Wang C
J Diabetes Investig. 2022; 14(1):6-11.
PMID: 36181402
PMC: 9807143.
DOI: 10.1111/jdi.13914.
Barc K, Szacka K, Nieporecki K, de Carvalho M, Gromicho M, Grosskreutz J
Aging Dis. 2020; 11(5):1021-1028.
PMID: 33014519
PMC: 7505264.
DOI: 10.14336/AD.2019.1120.
Lack of a Sense of Threat and Higher Emotional Lability in Patients With Chronic Microvascular Ischemia as Measured by Non-linear EEG Parameters.
Portnova G
Front Neurol. 2020; 11:122.
PMID: 32226407
PMC: 7080963.
DOI: 10.3389/fneur.2020.00122.
Post-stroke Mood and Emotional Disturbances: Pharmacological Therapy Based on Mechanisms.
Kim J
J Stroke. 2016; 18(3):244-255.
PMID: 27733031
PMC: 5066431.
DOI: 10.5853/jos.2016.01144.
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
Hammond F, Alexander D, Cutler A, DAmico S, Doody R, Sauve W
BMC Neurol. 2016; 16:89.
PMID: 27276999
PMC: 4899919.
DOI: 10.1186/s12883-016-0609-0.
Neuronal Dysregulation in Stroke-Associated Pseudobulbar Affect (PBA): Diagnostic Scales and Current Treatment Options.
Lapchak P
J Neurol Neurophysiol. 2015; 6(5).
PMID: 26693049
PMC: 4675467.
DOI: 10.4172/2155-9562.1000323.
A metabonomic investigation on the biochemical perturbation in post-stroke patients with depressive disorder (PSD).
Ding X, Liu R, Li W, Ni H, Liu Y, Wu D
Metab Brain Dis. 2015; 31(2):279-87.
PMID: 26537495
DOI: 10.1007/s11011-015-9748-z.
Prevalence of pseudobulbar affect symptoms and clinical correlates in nursing home residents.
Foley K, Konetzka R, Bunin A, Yonan C
Int J Geriatr Psychiatry. 2015; 31(7):694-701.
PMID: 26526856
PMC: 5215684.
DOI: 10.1002/gps.4374.
Psychiatric comorbidity and quality of life in patients with post-stroke emotional incontinence.
Choi D, Jeong B, Kang H, Kim S, Kim J, Shin I
Psychiatry Investig. 2014; 10(4):382-7.
PMID: 24474987
PMC: 3902156.
DOI: 10.4306/pi.2013.10.4.382.
Pseudobulbar affect: prevalence and management.
Ahmed A, Simmons Z
Ther Clin Risk Manag. 2013; 9:483-9.
PMID: 24348042
PMC: 3849173.
DOI: 10.2147/TCRM.S53906.
Effective use of sertraline for pathological laughing after severe vasospasm due to aneurysmal subarachnoid hemorrhage: case report.
Takeuchi H, Iwamoto K, Mukai M, Fujita T, Tsujino H, Iwamoto Y
Neurol Med Chir (Tokyo). 2013; 54(3):231-5.
PMID: 24201096
PMC: 4533423.
DOI: 10.2176/nmc.cr2012-0376.
PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions.
Brooks B, Crumpacker D, Fellus J, Kantor D, Kaye R
PLoS One. 2013; 8(8):e72232.
PMID: 23991068
PMC: 3749118.
DOI: 10.1371/journal.pone.0072232.
Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteers.
Schoedel K, Pope L, Sellers E
Clin Drug Investig. 2012; 32(3):157-69.
PMID: 22283559
DOI: 10.2165/11599870-000000000-00000.
Emotional incontinence in Chinese stroke patients--diagnosis, frequency, and clinical and radiological correlates.
Tang W, Chan S, Chiu H, Ungvari G, Wong K, Kwok T
J Neurol. 2004; 251(7):865-9.
PMID: 15258791
DOI: 10.1007/s00415-004-0450-z.
A self report measure of affective lability.
Moore S, Gresham L, Bromberg M, Kasarkis E, Smith R
J Neurol Neurosurg Psychiatry. 1997; 63(1):89-93.
PMID: 9221973
PMC: 2169647.
DOI: 10.1136/jnnp.63.1.89.
Poststroke depression: prevalence, course, and associated factors.
Hosking S, Marsh N, Friedman P
Neuropsychol Rev. 1996; 6(3):107-33.
PMID: 9104740
DOI: 10.1007/BF01874894.